Poly Medicure vs Windlas Biotech vs Shilpa Medicare: Which Stock Should You Track

Poly Medicure vs Windlas Biotech vs Shilpa Medicare starts with the core numbers most investors compare within the Medical Devices segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of September 2026 and will shift with daily price moves.

All three names sit in the Medical Devices bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.

Click Here – Get Free Investment Predictions

Poly Medicure, Windlas Biotech and Shilpa Medicare: Company Overview

Poly Medicure is a listed Indian company in the Medical Devices space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Windlas Biotech is a listed Indian company in the Medical Devices space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Shilpa Medicare is a listed Indian company in the Medical Devices space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Poly Medicure vs Windlas Biotech vs Shilpa Medicare: Valuation and Profitability Snapshot

Metric	Poly Medicure	Windlas Biotech	Shilpa Medicare
Market Cap (approx.)	Rs 17,504 crore	Rs 2,223 crore	Rs 20,284 crore
PE Ratio (TTM)	55.94	33.46	68.23
PB Ratio	5.64	3.83	7.83
Return on Equity (ROE)	10.37%	11.44%	9.39%
EPS (TTM, Rs)	30.87	32.20	15.20
Dividend Yield	0.20%	0.58%	0.06%
Debt to Equity	0.11	0.06	0.25
Book Value per Share (Rs)	306.45	281.35	132.49

Check the Univest Screener for Live Data

On valuation, Poly Medicure trades at a PE of 55.94 and a PB of 5.64, Windlas Biotech at a PE of 33.46 and a PB of 3.83, while Shilpa Medicare trades at a PE of 68.23 and a PB of 7.83. On return on equity, the three post 10.37%, 11.44% and 9.39% respectively, and on dividend yield they stand at 0.20%, 0.58% and 0.06%.

Poly Medicure vs Windlas Biotech vs Shilpa Medicare: Latest Quarterly Results

Company	Latest Quarter Revenue	Latest Quarter Net Profit	YoY Change (Revenue)	QoQ Change (Revenue)
Poly Medicure	Rs 558.79 crore	Rs 85.27 crore	+25.5%	+1.2%
Windlas Biotech	Rs 242.85 crore	Rs 15.99 crore	+17.0%	+2.2%
Shilpa Medicare	Rs 468.91 crore	Rs 100.88 crore	+43.0%	+6.9%

Quarterly figures above are the most recent reported quarter for each company (Q1 FY28, quarter ended June 2026), compared with the year-ago and preceding quarter.

Download the Univest iOS App or Univest Android App to track Poly Medicure, Windlas Biotech and Shilpa Medicare live prices.

What Should Investors Look at Beyond These Numbers?

Beyond the metrics above, investors comparing these three medical devices names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.

Conclusion

Poly Medicure vs Windlas Biotech vs Shilpa Medicare highlights how differently three companies in the same medical devices segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.

FAQs on Poly Medicure vs Windlas Biotech vs Shilpa Medicare

What is the market cap difference between Poly Medicure, Windlas Biotech and Shilpa Medicare?

Ans. As of September 2026, Poly Medicure has a market cap of approximately Rs 17,504 crore, Windlas Biotech is at approximately Rs 2,223 crore, and Shilpa Medicare is at approximately Rs 20,284 crore.

Which of the three has the highest PE ratio?

Ans. Among Poly Medicure, Windlas Biotech and Shilpa Medicare, the PE ratios stand at 55.94, 33.46 and 68.23 respectively as of September 2026.

Which of the three has the highest ROE?

Ans. Poly Medicure, Windlas Biotech and Shilpa Medicare post ROE of 10.37%, 11.44% and 9.39% respectively as of September 2026.

Which of these three stocks pays the highest dividend yield?

Ans. Poly Medicure, Windlas Biotech and Shilpa Medicare carry dividend yields of 0.20%, 0.58% and 0.06% respectively.

What is the debt to equity ratio for Poly Medicure, Windlas Biotech and Shilpa Medicare?

Ans. Poly Medicure carries a debt to equity of 0.11, Windlas Biotech of 0.06, and Shilpa Medicare of 0.25.

Which of the three trades at the highest price to book value?

Ans. Poly Medicure, Windlas Biotech and Shilpa Medicare trade at price to book ratios of 5.64, 3.83 and 7.83 respectively.

Is one of Poly Medicure, Windlas Biotech or Shilpa Medicare better than the others?

Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor's own criteria and research.